NCT02581696View on ClinicalTrials.gov

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Peptic Ulcer
Interventions
DRUG

Lafutidine

Lafutidine 10mg, 1 tablet, bid

DRUG

Irsogladine maleate

Irsogladine maleate 2mg, 2 tablet, qd

Trial Locations (1)

Unknown

The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

The Catholic University of Korea

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY